Court Decisions Bullish 8

100,000+ Roundup Suits at Risk After 7-2 SCOTUS Preemption Ruling

The Supreme Court’s 7-2 decision in Monsanto v. Durnell holds that FIFRA preempts state failure-to-warn claims requiring cancer warnings beyond EPA-approved labels. The ruling overturns a $1M+ verdict and provides a powerful preemption defense for pesticide manufacturers facing over 100,000 personal injury lawsuits.

· 4 min read · Verified by 2 sources ·
Share

Key Takeaways

  • The Supreme Court’s 7-2 decision in Monsanto v.
  • Durnell holds that FIFRA preempts state failure-to-warn claims requiring cancer warnings beyond EPA-approved labels.
  • The ruling overturns a $1M+ verdict and provides a powerful preemption defense for pesticide manufacturers facing over 100,000 personal injury lawsuits.

Mentioned

Monsanto (subsidiary of Bayer AG) company BAYRY Roundup product U.S. Supreme Court organization Justice Brett M. Kavanaugh person Environmental Protection Agency (EPA) organization International Agency for Research on Cancer (IARC) government-body Mr. Durnell person Bayer AG company BAYRY

Key Intelligence

Key Facts

  1. 1The Supreme Court ruled 7-2 in Monsanto Co. v. Durnell on June 25, 2026, that FIFRA preempts state-law failure-to-warn claims requiring cancer warnings beyond EPA-approved labels.
  2. 2The decision reversed a Missouri jury verdict of more than $1 million and will affect over 100,000 pending lawsuits alleging Roundup caused cancer.
  3. 3EPA has repeatedly concluded over decades that glyphosate is “not likely to be carcinogenic to humans” and approved Roundup labels without a cancer warning.
  4. 4The International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic” in 2017 and 2019, contrasting with EPA’s stance.
  5. 5Justice Brett Kavanaugh wrote the majority opinion, holding that state tort duties are “requirements” for labeling under FIFRA §136v(b).
  6. 6The ruling narrows product liability exposure for pesticide registrants and may influence preemption analyses under other federal labeling statutes.

Who's Affected

Monsanto/Bayer
companyPositive
Pesticide registrants
industryPositive
Roundup plaintiffs (100,000+)
individualsNegative
State courts
judiciaryNegative

FIFRA’s express preemption provision leaves little room for states to impose labeling obligations that differ from EPA’s approved labeling.

Justice Brett M. Kavanaugh Associate Justice, U.S. Supreme Court

Majority opinion in Monsanto Co. v. Durnell

Analysis

For product liability defense counsel, the Supreme Court’s decision in Monsanto v. Durnell is a game-changer. The Court’s clear holding that FIFRA preempts state tort duties imposing additional labeling requirements dismantles the claim framework that fueled the massive Roundup litigation. As Justice Kavanaugh’s majority opinion explains, EPA’s registration decision is a binding federal labeling requirement, and state failure-to-warn claims that would add cancer warnings are directly preempted. This ruling not only shields registrants from a wave of pending suits but also signals a broader federal uniformity principle that may apply to other federal labeling statutes.

On June 25, 2026, the U.S. Supreme Court issued a landmark ruling in Monsanto Co. v. Durnell, holding that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) expressly preempts state-law failure-to-warn claims that would require pesticide labels to include cancer warnings beyond those approved by the Environmental Protection Agency (EPA). The 7-2 decision, authored by Justice Brett Kavanaugh, reversed a Missouri jury verdict of over $1 million and swept away the legal foundation for more than 100,000 pending lawsuits alleging that long-term use of Monsanto’s glyphosate-based Roundup herbicide causes non-Hodgkin’s lymphoma. The ruling is one of the most significant pesticide-law decisions in decades and clarifies the scope of federal preemption under a statute that mandates nationwide uniformity in pesticide labeling.

A Missouri state jury found Monsanto liable on a failure-to-warn theory and awarded more than $1 million in damages; the Missouri Court of Appeals affirmed.

At the heart of the case was the direct conflict between state tort duties and the EPA’s repeated scientific conclusions—over several decades—that glyphosate is “not likely to be carcinogenic to humans” and that Roundup labels may be registered without a cancer warning. In contrast, the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” in 2017 and again in 2019, fueling an explosion of litigation. The plaintiff, Mr. Durnell, had used Roundup for approximately 20 years and alleged it caused his non-Hodgkin’s lymphoma. A Missouri state jury found Monsanto liable on a failure-to-warn theory and awarded more than $1 million in damages; the Missouri Court of Appeals affirmed. Monsanto, a subsidiary of Bayer AG, appealed to the Supreme Court, which granted certiorari (Case No. 24-1068) and reversed.

The Court’s analysis centered on FIFRA’s express preemption provision, Section 136v(b), which prohibits states from imposing “any requirements for labeling or packaging in addition to or different from” those required under FIFRA. Justice Kavanaugh wrote that state tort duties constitute “requirements” for purposes of preemption. The EPA’s registration process, the Court reasoned, is not merely administrative: before registering a pesticide, EPA must determine that its labeling contains all warnings necessary to protect human health and the environment and is not false or misleading. Once approved, that label is a binding federal requirement. Allowing a state jury to impose a cancer warning would conflict directly with the EPA’s determination that no such warning is needed.

What to Watch

The practical implications are enormous. For pesticide manufacturers and registrants, the decision provides a powerful preemption defense that will likely bar the vast majority of pending Roundup failure-to-warn claims. The ruling also narrows exposure for any pesticide product where the EPA has reviewed and approved the label’s safety content. However, the decision does not reach other potential theories—such as design defect or negligent testing—where plaintiffs might still argue state law duties that do not directly require labeling changes. Moreover, the ruling is limited to FIFRA; its reasoning may influence preemption analyses under other federal labeling statutes like the Food, Drug, and Cosmetic Act or the Toxic Substances Control Act, but each statute’s language will govern.

Looking ahead, the decision will likely drive down settlement values and may prompt Congress to consider amendments to FIFRA if public pressure builds around the IARC’s carcinogenicity finding. For now, the Court has drawn a bright line: states cannot second-guess the EPA’s safety determinations through tort law when it comes to pesticide labeling. The 100,000-plus plaintiffs who relied on IARC’s classification to support state-law cancer warnings will find their claims preempted, marking a decisive victory for Monsanto and the broader pesticide industry.

Timeline

Timeline

  1. IARC Classifies Glyphosate as Probably Carcinogenic

  2. IARC Reiterates Finding; EPA Maintains Position

  3. U.S. Supreme Court Rules 7-2 in Monsanto v. Durnell

Sources

Sources

Based on 2 source articles

Cite This Page

"100,000+ Roundup Suits at Risk After 7-2 SCOTUS Preemption Ruling." Legal & RegTech Intelligence Brief, June 27, 2026. https://getlegalbrief.com/story/scotus-fifra-preemption-roundup-100k

How we covered this story

Every story in our legal coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the legal space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.

Sources are only linked to a story once they clear our classification pipeline at a minimum 35 percent relevance threshold. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong in this story — a wrong fact, a broken source link, a misattributed entity? Report a data issue.